Department of Cardiology, The Sixth People's Hospital of Chengdu, Chengdu, 610051, China.
Department of Cardiology, West China Hospital, Sichuan University, No. 37 GuoXue Street, Chengdu, 610041, China.
Intern Emerg Med. 2019 Jan;14(1):161-175. doi: 10.1007/s11739-018-1935-6. Epub 2018 Sep 1.
Several observational studies have shown that postoperative acute kidney injury (AKI) may significantly worsen the prognosis of a transcatheter aortic valve implantation (TAVI). The purpose of this systematic review and meta-analysis is to evaluate the recent evidence on the impact of AKI on clinical outcomes following TAVI. A comprehensive search in PubMed, Embase and the Cochrane Library was performed for relevant studies by two independent investigators. We pooled the odds ratio (OR) from individual studies, and performed heterogeneity, quality assessment and publication bias analysis. Forty-three eligible studies comprising 544,112 patients were included. Postoperative AKI not only significantly increased the risk for short-term and long-term all-cause mortality (OR 6.25, 95% CI 5.72-6.83, P < 0.00001; OR 3.49, 95% CI 2.78-4.40, P < 0.00001, respectively), but also increased the risk for early myocardial infarction (OR 3.98, 95% CI 1.90-8.31, P = 0.0002), major and life-threatening bleeding (OR 1.51, 95% CI 1.12-2.03, P = 0.007; OR 2.35, 95% CI 1.80-3.06, P < 0.00001, respectively), major vascular complications (OR 1.69, 95% CI 1.30-2.18, P < 0.0001), need for blood transfusion (OR 2.15, 95% CI 1.89-2.46, P < 0.00001) renal replacement therapy (OR 22.36, 95% CI 11.88-42.12, P = 0.0002) and cerebrovascular accidents (OR 1.92, 95% CI 1.23-2.98, P = 0.004). Acute kidney injury following TAVI is associated with increased postoperative mortality and morbidity. Future efforts are required to determine whether early prevention of post-procedural AKI after TAVI impacts upon clinical outcomes.
几项观察性研究表明,术后急性肾损伤(AKI)可能显著恶化经导管主动脉瓣植入术(TAVI)的预后。本系统评价和荟萃分析的目的是评估 AKI 对 TAVI 后临床结局的近期证据。两名独立研究者在 PubMed、Embase 和 Cochrane 图书馆中进行了全面搜索,以寻找相关研究。我们从个体研究中汇总了比值比(OR),并进行了异质性、质量评估和发表偏倚分析。纳入了 43 项符合条件的研究,共 544112 例患者。术后 AKI 不仅显著增加了短期和长期全因死亡率的风险(OR 6.25,95%CI 5.72-6.83,P<0.00001;OR 3.49,95%CI 2.78-4.40,P<0.00001),而且还增加了早期心肌梗死(OR 3.98,95%CI 1.90-8.31,P=0.0002)、主要和危及生命的出血(OR 1.51,95%CI 1.12-2.03,P=0.007;OR 2.35,95%CI 1.80-3.06,P<0.00001)、主要血管并发症(OR 1.69,95%CI 1.30-2.18,P<0.0001)、输血需求(OR 2.15,95%CI 1.89-2.46,P<0.00001)、肾脏替代治疗(OR 22.36,95%CI 11.88-42.12,P=0.0002)和脑血管意外(OR 1.92,95%CI 1.23-2.98,P=0.004)的风险。TAVI 术后 AKI 与术后死亡率和发病率增加相关。需要进一步努力确定 TAVI 后早期预防术后 AKI 是否会影响临床结局。